Vaccine development is a special industry. I could include all biological products in this category. It's already very expensive to market or scale up technologies using good manufacturing practices. You also have to get enough products to be able to conduct clinical trials, which are also very expensive. Facilities are needed for immunomonitoring vaccines. All of these things take a lot of money, and Canada will need to invest in all of these areas.
On February 16th, 2021. See this statement in context.